China NMPA Drug Inspection - Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd. - Vitamin D2 pills
China NMPA drug inspection for Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd. published August 01, 2012. Drug: Vitamin D2 pills. The National Medical Products Administration (NMPA), operating as the State Food and Drug Administration (SFDA) at the t
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd. published August 01, 2012. Drug: Vitamin D2 pills. The National Medical Products Administration (NMPA), operating as the State Food and Drug Administration (SFDA) at the t
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox